Trial Profile
Genous in Patients with Reduced Antiplatelet Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2010
Price :
$35
*
At a glance
- Drugs Anti-CD34 monoclonal antibody (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 17 Feb 2010 New trial record
- 15 Feb 2010 Results have been presented at JIM 2010 - Joint Interventional Meeting, according to an OrbusNeich Medical media release.